Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 128726, 8 pages
http://dx.doi.org/10.1155/2014/128726
Research Article

Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial

1Center for Kampo Medicine, Faculty of Environment and Information Study, Keio University School of Medicine, 5322 Endo, Fujisawa, Kanagawa 252-0882, Japan
2Division of Internal Medicine, Saiseikai Central Hospital, 1-14-17 Mita, Minato-ku, Tokyo 108-0073, Japan
3Department of Clinical Research and Informatics, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
4Department of Ophthalmology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
5Department of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
6Tokyo Dental College, Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, Chiba 272-8513, Japan

Received 21 July 2013; Revised 29 November 2013; Accepted 16 February 2014; Published 9 April 2014

Academic Editor: Gregory A. Plotnikoff

Copyright © 2014 K. Watanabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Health and Nutrition Survey, 2013, http://www.mhlw.go.jp/houdou/2008/12/h1225-5.html.
  2. Diabetes Atlas, 2013, http://www.idf.org/diabetesatlas.
  3. I. M. Stratton, A. I. Adler, H. A. W. Neil et al., “Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study,” British Medical Journal, vol. 321, no. 7258, pp. 405–412, 2000. View at Google Scholar · View at Scopus
  4. S. Tesfaye, L. K. Stevens, J. M. Stephenson et al., “Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study,” Diabetologia, vol. 39, no. 11, pp. 1377–1384, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Hemmingsen, S. S. Lund, C. Gluud et al., “Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials,” British Medical Journal, vol. 343, p. d6898, 2011. View at Google Scholar · View at Scopus
  6. A. Singh, R. Donnino, H. Weintraub, and A. Schwartzbard, “Effect of strict glycemic control in patients with diabetes mellitus on frequency of macrovascular events,” American Journal of Cardiology, vol. 112, no. 7, pp. 1033–1038, 2013. View at Publisher · View at Google Scholar
  7. P. Gæde, H. Lund-Andersen, H. Parving, and O. Pedersen, “Effect of a multifactorial intervention on mortality in type 2 diabetes,” New England Journal of Medicine, vol. 358, no. 6, pp. 580–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Redmon, A. G. Bertoni, S. Connelly et al., “Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes,” Diabetes Care, vol. 33, no. 6, pp. 1153–1158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Rejeski, E. H. Ip, A. G. Bertoni et al., “Lifestyle change and mobility in obese adults with type 2 diabetes,” New England Journal of Medicine, vol. 366, no. 13, pp. 1209–1217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Lubart, R. Segal, J. Wainstein, G. Marinov, A. Yarovoy, and A. Leibovitz, “Evaluation of an intra-institutional diabetes disease management program for the glycemic control of elderly long-term care diabetic patients,” Geriatrics & Gerontology International, 2013. View at Publisher · View at Google Scholar
  11. K. Tamaki, N. Taniguchi, I. Matuhata, and N. Kanai, “Effects of moxibustion and goshajinkigan for spontaneous fatty II diabetes rat,” Kampo Medicine, vol. 56, no. 4, pp. 555–560, 2005 (Japanese). View at Publisher · View at Google Scholar
  12. Y. Hirotani, K. Ikeda, and M. Myoutoku, “Effects of the herbal medicine goshajinkigan on sucrose-rich diet-induced hypertriglyceridemia in rats,” Journal of Traditional Medicines, vol. 26, no. 4, pp. 187–193, 2009. View at Google Scholar
  13. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei, “Effect of Gosha-jinki-gan, a Kampo medicine, on enhanced platelet aggregation in streptozotocin-induced diabetic rats,” Japanese Journal of Pharmacology, vol. 78, no. 1, pp. 87–91, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei, “Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice,” Japanese Journal of Pharmacology, vol. 79, no. 2, pp. 169–175, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Suzuki, K. Goto, A. Ishige, Y. Komatsu, and J. Kamei, “Antinociceptive mechanism of Gosha-jinki-gan in streptozotocin-induced diabetic animals: role of nitric oxide in the periphery,” Japanese Journal of Pharmacology, vol. 79, no. 3, pp. 387–391, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Nagaki, S. Hayasaka, Y. Hayasaka et al., “Effects of Goshajinkigan on corneal sensitivity, superficial punctate keratopathy and tear secretion in patients with insulin-dependent diabetes mellitus,” American Journal of Chinese Medicine, vol. 31, no. 1, pp. 103–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Yokozawa, N. Yamabe, E. J. Cho, T. Nakagawa, and S. Oowada, “A study on the effects to diabetic nephropathy of hachimi-jio-gan in rats,” Nephron-Experimental Nephrology, vol. 97, no. 2, pp. e38–e48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Nakagawa, T. Yokozawa, N. Yamabe et al., “Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats,” Journal of Pharmacy and Pharmacology, vol. 57, no. 9, pp. 1205–1212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Yamabe and T. Yokozawa, “Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima Fatty rat: a model of human type 2 diabetes mellitus,” Journal of Pharmacy and Pharmacology, vol. 58, no. 4, pp. 535–545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Yamabe, K. S. Kang, E. Goto, T. Tanaka, and T. Yokozawa, “Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats,” Biological and Pharmaceutical Bulletin, vol. 30, no. 3, pp. 520–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Y. Kim, T. Yokozawa, E. J. Cho, and N. Yamabe, “Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress,” Journal of Pharmacy and Pharmacology, vol. 56, no. 10, pp. 1299–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Cameron-Schaefer, K. Kondo, A. Ishige et al., “Maintaining the redox-balance intact: Gosha-jinki-gan but not insulin activates retinal soluble guanylate cyclase in diabetic rats,” Ophthalmic Research, vol. 38, no. 2, pp. 95–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sakamoto, Y. Sato, and Y. Goto, “Treatment of diabetic neuropathy with traditional oriental medicine,” Journal of the Japan Diabetes Society, vol. 30, no. 8, pp. 729–737, 1987. View at Google Scholar · View at Scopus
  24. M. Tawata, A. Kurihara, K. Nitta, E. Iwase, N. Gan, and T. Onaya, “The effects of Goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy,” Diabetes Research and Clinical Practice, vol. 26, no. 2, pp. 121–128, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Aida, H. Shindo, M. Tawata, and T. Onaya, “Inhibition of aldose reductase activities by kampo medicines,” Planta Medica, vol. 53, no. 2, pp. 131–135, 1987. View at Google Scholar · View at Scopus
  26. K. Aida, M. Tawata, H. Shindo et al., “The existence of aldose reductase inhibitors in some kampo medicines (oriental herb prescriptions),” Planta Medica, vol. 55, no. 1, pp. 22–26, 1989. View at Google Scholar · View at Scopus
  27. T. Kono, N. Mamiya, N. Chisato et al., “Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 418481, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Uno, I. Ohsawa, M. Tokudome, and Y. Sato, “Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 69, no. 2, pp. 129–135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Hu, J. Sato, Y. Oshida, M. Xu, G. Bajotto, and Y. Sato, “Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats,” Diabetes Research and Clinical Practice, vol. 59, no. 2, pp. 103–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. Action to Control Cardiovascular Risk in Diabetes Study Group, H. C. Gerstein, M. E. Miller et al., “Effects of intensive glucose lowering in type 2 diabetes,” The New England Journal of Medicine, vol. 358, pp. 2545–2559, 2008. View at Publisher · View at Google Scholar
  31. Advance Collaborative Group, A. Patel, S. MacMahon et al., “Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 358, pp. 2560–2572, 2008. View at Publisher · View at Google Scholar